Hello all!
I've been benefiting from so many of the things you all have shared in the past few months. I haven't felt up to posting myself as life has been a bit overwhelming. But I'm hoping to contribute a bit of my story going forward in the hopes that someone might benefit from my experience as I have benefited yours.
So the purpose of this post is just to say 'hello'. However I'll try to summarize a lot of the diagnostic details for those who want to compare.
Age: 49, single father with two kids (11 and 9)
PSA at diagnosis: 114. I've asked for frequent PSA tests and my results before starting treatment have varied 114 +/- 28 (low 86, high 142). Within the first month of treatment my PSA dropped to from 116 to 3.4. A couple of weeks laster it was 2.6.
Current assessment: (cT3 cN1 cM1)
Biopsy results (12 cores):
1. right base: GS 9(4+5). Tumour/span 100% & 90%
2. right mid: GS 8(4+4). Tumour/spans 60%, 40%
3. right apex: GS 8(4+4). Tumour/spans 80% & 50%
4. left base: GS 8(4+4). (only one core had tumour) span 1%
5. left mid: GS 8(4+4). (one one core had tumour) 35%
6. left apex: GS 7(3+4). (one core had tumor) 50%
Several DREs before hand had noticed moderate firmness on right side
Scans
- MRI estimated prostate at 51ml with a large prostatic carcinoma
- probable extra capsular spread
- probable lymph node metastasis around the prostate.
- no signs of spread to seminal vesicle, neuromuscular bundles or adjacent organs seem
Current Treatment plan
Started Firmagon (I just took my 3rd monthly injection). In the first six weeks of Firmagon my PSA dropped from 116 -> 2.6, which my surgical oncologist characterized as "average response", but a good sign.
After the 6th treatment, I will have another physical exam and MRI/CT. Possibly a PET PSMA scan, for which I will have to go to the USA.
Surgical oncologist has said no option is off the table, but if the tumour shrinks he is hoping to perform RP including the lymph nodes that were affected.
There is a strong suspicion that, although no distant spread was detected during imaging, there is likely microscopic mets. With little concrete data, he estimates at 10-15% chance that RP can get it all and be curative. He indicated (using historical data) that the current nomograms indicate a 50% change of 5 year survival.